Meiji Yasuda Asset Management Co Ltd.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1491685
Tokyo, M0
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$260,016
-$52,130 QoQ
Shares Held
417
+3.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#977
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Meiji Yasuda Asset Management Co Ltd. holds $10,170,872 across 12 Biotechnology names. REGN ranks #11 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,740 | $6,328,340 | |
| 2 | INCY |
Incyte Corp
|
5,097 | $577,795 | |
| 3 | RPRX |
Royalty Pharma plc
|
8,098 | $454,054 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,780 | $445,171 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
10,402 | $368,126 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,452 | $349,888 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,085 | $326,617 | |
| 8 | EXEL |
Exelixis, Inc.
|
5,818 | $316,557 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $260,016 | 417 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $312,146 | 404 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $387,478 | 502 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $393,026 | 699 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $398,475 | 759 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,464,437 | 2,309 | Shares | Defined | 2025-05-16 | |
| 2024-12-31 | $1,663,290 | 2,335 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,491,438 | 2,370 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,432,083 | 2,314 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $2,112,665 | 2,195 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,422,696 | 3,897 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,253,160 | 3,953 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,502,467 | 2,091 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,714,003 | 2,086 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,955,223 | 4,096 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,160,774 | 6,040 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $3,747,764 | 6,340 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $5,671,170 | 8,120 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $5,277,612 | 8,357 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,943,715 | 8,169 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,703,465 | 8,421 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,965,386 | 8,381 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,773,572 | 7,811 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,648,086 | 6,517 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $4,550,774 | 7,297 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $721,204 | 1,477 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||